Jane Tezapsidis
Professor
Science
EMAIL: jtezapsidis@bmcc.cuny.edu
Office: N-698L
Office Hours:
Phone: +1 (212) 776-6894
Dr Jane M. Johnston (Tezapsidis) is regarded as an expert in molecular neuroscience relating to Alzheimer’s and Parkinson’s diseases, as well as pre-clinical drug development. She has garnered more than 25 years of research experience in cellular neuroscience and published more than 40 peer-reviewed articles in the field (download publication list below).
Dr Tezapsidis has been teaching Anatomy/Physiology and Pharmacology at BMCC since 2005. She has also served as an Adjunct Professor in the graduate Physiology and Pharmacology program at Rutgers New Jersey Medical School, and in the Albert Einstein College of Medicine in Bronx, New York. In addition to her academic positions, she has consulted for industry at Johnson & Johnson and conducts drug development at Neurotez, a biotechnology company based in New Jersey.
Dr Tezapsidis graduated with a Ph.D. in Biochemistry from the Imperial College of Science, Technology and Medicine at the University of London, and she was a Visiting Fellow at the National Institutes of Neurological Disorders and Stroke at the National Institutes of Health (NIH) in Bethesda Maryland.
Expertise
Cellular biology, molecular biology, microbiology
Degrees
- Ph.D. Imperial College of Science, Technology and Medicine/Univ. of London, Biochemistry,
Courses Taught
- This two-semester course acquaints students with the basic properties of living systems: metabolism, growth, responsiveness and reproduction at the cellular and organism levels as illustrated by assorted plants and animals. Two terms required.
Course Syllabus - This two-semester course explores the human body as an integrated, functional complex of systems. Terminology, structure and function of each organ-system, with emphasis on their interrelationships, are explained. Required of students in the health services technologies; available to all other students for elective credit.
Prerequisite for BIO 426 is BIO 425. Two terms required. Prerequisite: CHE 118 or CHE 121, or departmental approval NOTE: BIO 425 and BIO 426 do not meet the science requirements in the liberal arts curriculum.
Course Syllabus - This two-semester course explores the human body as an integrated, functional complex of systems. Terminology, structure and function of each organ-system, with emphasis on their interrelationships, are explained. Required of students in the health services technologies; available to all other students for elective credit.
Prerequisite for BIO 426 is BIO 425. Two terms required. Prerequisite: CHE 118 or CHE 121, or departmental approval NOTE: BIO 425 and BIO 426 do not meet the science requirements in the liberal arts curriculum.
Course Syllabus - Fundamental principles and concepts in pharmacology are considered. Particular attention is given to drug action and interaction, and to the effect of drugs and toxic substances in the human organism. This course is required in selected programs in Allied Health Sciences; available to all other students for elective credit. It is recommended that students complete HIT 103, Medical Terminology I, before registering for this course.
Prerequisite: BIO 426 and CHE 118 or CHE 121, or permission of the department
Course Syllabus - This is an introduction to the fundamental principles of human nutrition. The nutrient composition of various foods is examined as well as the manner in which the nutrients are metabolized and used by the human body.
Prerequisite: One semester of science or departmental approval
Course Syllabus
Research and Projects
Publications
- ,
- ,
Honors, Awards and Affiliations
Additional Information
FUNDED RESEARCH
2018-2019 PSC-CUNY Research Award Forskolin induces apoptosis in SH-SY5Y neuroblastoma Cells
2014-2015 BMCC Faculty Publication Award Improving viability of dopaminergic neurons in culture
2010-2011 Bridge Award New Jersey Commission on Science and Technology Role: Co-director. Director: Nikolaos Tezapsidis Ph.D.
2008-2010 Postdoctoral Fellowship Award (for Steven Greco), New Jersey Commission on Science and Technology .Role: Co-director. Director Nikolaos Tezapsidis Ph.D
2007-2013 (R43, R44 AG029670), National Institutes of Health Leptin as a Treatment for Alzheimer’s DiseaseRole: Co-PI. PI: Tezapsidis
2008-2009 PSC-CUNY (69864 -00 39) Faculty in Service Award
2007-2008 PSC-CUNY (69864-00 38) Faculty in Service Award
1997-2000 The Alzheimer’s Association Presenilins and Alzheimer’s Disease (3 years). Role: Co-PI with Dr. N. Tezapsidis, Mt. Sinai School of Medicine, N.Y.
1993-1994 Molecular and Cellular Neurobiology Fellowship(2 years). Fogarty International Center. National Institutes of Health Sponsored by Dr. J.W. Commission. National Institute for Neurological Disorders and Stroke, Bethesda, Maryland.
1992 Regional Research Committee, North West Thames Regional Health Authority, London U.K. Abnormalities of the Human Pituitary Dopamine D2 Receptor (ref C16/17)
